| Primary |
| Product Used For Unknown Indication |
27.9% |
| Malignant Respiratory Tract Neoplasm |
24.9% |
| Lung Neoplasm Malignant |
18.3% |
| Pancreatic Carcinoma |
8.8% |
| Non-small Cell Lung Cancer |
8.6% |
| Lung Adenocarcinoma |
2.2% |
| Bronchial Carcinoma |
1.4% |
| Lung Carcinoma Cell Type Unspecified Stage 0 |
1.1% |
| Lung Cancer Metastatic |
0.7% |
| Tracheal Cancer |
0.7% |
| Bone Neoplasm Malignant |
0.7% |
| Neoplasm Malignant |
0.7% |
| Metastases To Liver |
0.7% |
| Hepatic Neoplasm Malignant |
0.6% |
| Brain Neoplasm Malignant |
0.5% |
| Renal Cancer |
0.5% |
| Pain |
0.4% |
| Hypertension |
0.4% |
| Drug Use For Unknown Indication |
0.4% |
| Metastases To Nervous System |
0.4% |
|
| Death |
75.5% |
| Rash |
8.4% |
| Disease Progression |
2.7% |
| Vomiting |
1.6% |
| Malaise |
1.2% |
| Weight Decreased |
1.2% |
| Malignant Neoplasm Progression |
1.1% |
| Diarrhoea |
1.1% |
| Lung Neoplasm Malignant |
0.9% |
| Respiratory Failure |
0.9% |
| Pneumonia |
0.9% |
| Neoplasm Malignant |
0.6% |
| Incorrect Dose Administered |
0.6% |
| Dyspnoea |
0.6% |
| Pulmonary Embolism |
0.6% |
| Nausea |
0.5% |
| Haemoptysis |
0.5% |
| Pyrexia |
0.5% |
| Stomatitis |
0.4% |
| Thrombocytopenia |
0.4% |
|
| Secondary |
| Product Used For Unknown Indication |
21.7% |
| Lung Neoplasm Malignant |
19.9% |
| Non-small Cell Lung Cancer |
11.1% |
| Malignant Respiratory Tract Neoplasm |
7.4% |
| Pancreatic Carcinoma |
5.8% |
| Bronchial Carcinoma |
5.4% |
| Drug Use For Unknown Indication |
4.4% |
| Tracheal Cancer |
3.6% |
| Bone Neoplasm Malignant |
3.5% |
| Metastases To Liver |
2.8% |
| Lung Adenocarcinoma |
2.5% |
| Hepatic Neoplasm Malignant |
2.2% |
| Renal Cancer |
1.8% |
| Pain |
1.4% |
| Hypertension |
1.2% |
| Metastases To Nervous System |
1.2% |
| Neoplasm Malignant |
1.2% |
| Nausea |
0.9% |
| Prophylaxis |
0.9% |
| Brain Neoplasm Malignant |
0.9% |
|
| Death |
55.5% |
| Rash |
12.8% |
| Disease Progression |
7.1% |
| Vomiting |
3.3% |
| Weight Decreased |
2.5% |
| Pneumonia |
1.9% |
| Diarrhoea |
1.7% |
| Pyrexia |
1.7% |
| Malaise |
1.7% |
| Malignant Neoplasm Progression |
1.4% |
| Nausea |
1.2% |
| Fatigue |
1.1% |
| Lung Neoplasm Malignant |
1.1% |
| Metastases To Central Nervous System |
1.1% |
| Lung Cancer Metastatic |
1.1% |
| Thrombocytopenia |
1.1% |
| Pain |
1.0% |
| Renal Failure Acute |
1.0% |
| Pleural Effusion |
0.9% |
| Dehydration |
0.8% |
|
| Concomitant |
| Non-small Cell Lung Cancer |
22.9% |
| Lung Neoplasm Malignant |
9.9% |
| Pain |
8.5% |
| Pancreatic Carcinoma |
6.6% |
| Unevaluable Event |
6.0% |
| Drug Use For Unknown Indication |
5.7% |
| Prophylaxis |
4.8% |
| Product Used For Unknown Indication |
4.4% |
| Metastases To Bone |
4.1% |
| Rheumatoid Arthritis |
3.4% |
| Breast Cancer Metastatic |
3.3% |
| Pancreatic Carcinoma Metastatic |
3.3% |
| Nausea |
3.0% |
| Adenocarcinoma |
2.7% |
| Lung Adenocarcinoma |
2.5% |
| Cancer Pain |
1.8% |
| Hepatic Neoplasm Malignant |
1.8% |
| Premedication |
1.8% |
| Abdominal Pain |
1.7% |
| Adenocarcinoma Pancreas |
1.7% |
|
| Weight Decreased |
11.6% |
| Vomiting |
11.1% |
| Death |
10.1% |
| Rash |
10.1% |
| Pyrexia |
5.0% |
| Myocardial Infarction |
4.5% |
| Pneumonia |
4.5% |
| Thrombocytopenia |
4.5% |
| Disease Progression |
4.0% |
| Osteonecrosis |
4.0% |
| Weight Bearing Difficulty |
4.0% |
| Malignant Neoplasm Progression |
3.5% |
| Tooth Extraction |
3.5% |
| Dyspnoea |
3.0% |
| Lung Neoplasm Malignant |
3.0% |
| Pain In Jaw |
3.0% |
| Pancreatic Carcinoma |
3.0% |
| Chest Pain |
2.5% |
| Drug Ineffective |
2.5% |
| Incorrect Dose Administered |
2.5% |
|
| Interacting |
| Product Used For Unknown Indication |
41.2% |
| Cervicobrachial Syndrome |
5.9% |
| Dementia Alzheimer's Type |
5.9% |
| Lung Neoplasm Malignant |
5.9% |
| Cough |
3.9% |
| Drug Use For Unknown Indication |
3.9% |
| Lung Adenocarcinoma Recurrent |
3.9% |
| Neuralgia |
3.9% |
| Neuropathy Peripheral |
3.9% |
| Bronchitis |
2.0% |
| Cardiac Failure |
2.0% |
| Constipation |
2.0% |
| Diarrhoea |
2.0% |
| Dyslipidaemia |
2.0% |
| Dysuria |
2.0% |
| Embolism Venous |
2.0% |
| Gastritis |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Muscle Spasms |
2.0% |
| Pain |
2.0% |
|
| Weight Decreased |
33.3% |
| Rash |
16.7% |
| Drug Interaction |
8.3% |
| Haematemesis |
8.3% |
| Haematoma |
8.3% |
| Lung Cancer Metastatic |
8.3% |
| Rhabdomyolysis |
8.3% |
| Ventricular Tachycardia |
8.3% |
|
